Uncategorized
FDA approves labeling clarifications for Eylea
The FDA has approved updated U.S. prescribing information for Eylea, Regeneron announced.The update was made in response to concerns expressed by the American Society of Retina Specialists about misinterpretation of label language, the society said in a press release.